|
Volume 271, Number 44,
Issue of November 1, 1996
pp. 27760-27764
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Role of Hydroperoxyeicosatetraenoic Acids in Oxidative
Stress-induced Activating Protein 1 (AP-1) Activity*
(Received for publication, April 4, 1996, and in revised form, July 22, 1996)
Gadiparthi N.
Rao
,
Wayne C.
Glasgow
§,
Thomas E.
Eling
§ and
Marschall S.
Runge
From the Division of Cardiology, University of Texas Medical
Branch, Galveston, Texas 77555 and the § Laboratory of
Molecular Biophysics, NIEHS, National Institutes of Health, Research
Triangle Park, North Carolina 27709
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
We have previously reported that hydrogen
peroxide, an active oxygen species and a cellular oxidant, induces
c-Fos and c-Jun mRNA expression and DNA synthesis in vascular
smooth muscle cells and that these events require arachidonic acid
release and metabolism through the lipoxygenase pathway. Here we have
identified the eicosanoids that mediate the hydrogen peroxide-induced
growth-related events in these cells. Hydrogen peroxide stimulated the
production of 12- and 15-hydroperoxyeicosatetraenoic acids in vascular
smooth muscle cells. Both 12- and 15-hydroperoxyeicosatetraenoic acids
induced the expression of c-Fos and c-Jun protein and increased
activating protein 1 (AP-1) activity, as measured by AP-1-DNA binding
and AP-1-dependent human collagenase promoter-driven
chloramphenicol acetyltransferase reporter gene
transcription. Hydrogen peroxide and arachidonic acid also
induced the expression of c-Fos and c-Jun protein and AP-1 activity.
Nordihydroguaiaretic acid, an inhibitor of the lipoxygenase pathway,
significantly inhibited both hydrogen peroxide and arachidonic
acid-stimulated c-Fos and c-Jun protein expression and AP-1 activity.
Together, these findings suggest that hydrogen peroxide induces the
production of eicosanoids and that the eicosanoids are potential
mediators of the oxidative stress-stimulated growth-related events in
vascular smooth muscle cells.
INTRODUCTION
Active oxygen (AO)1 species such as
superoxide anion, hydrogen peroxide, and hydroxyl radicals are
constantly formed in all aerobic cells as a result of mitochondrial
electron transport and several enzymatic reactions such as xanthine
oxidase, NADH/NADPH oxidase, monooxygenases, and cyclooxygenases
(1, 2, 3). These AO species damage DNA, lipids, and protein (1, 2, 3).
However, several cellular antioxidant defenses such as superoxide
dismutase, catalase, glutathione peroxidase, vitamin C, and vitamin E
protect cells from such toxins (1, 2, 3). The production of AO species in
any given cell varies, depending on its state of metabolic activity or
stimulus. For example, neutrophils generate a large amount of AO
species upon activation (4). Likewise, ischemic reperfusion results in
increased production of AO species (5). In addition, some AO species
such as hydrogen peroxide penetrate the plasma membrane (5). Therefore,
the generation of AO species in one cell type can affect levels in
neighboring cells or cell types. AO species levels may also increase in
cells when the ability of the cells to scavenge them decreases. All of
these conditions with deficient protective mechanisms may lead cells to
oxidative stress.
Oxidative stress has been implicated in the pathogenesis of diseases
such as atherosclerosis and cancer, as well as in aging and in some
inflammatory disorders (5, 6, 7, 8, 9). The major effects of AO species are
damage to DNA and oxidative inactivation of certain enzymes (1, 2).
However, recent work from several laboratories shows that AO species
under nontoxic levels can stimulate the expression of early
growth-response gene mRNAs and can cause growth in some cell types
(10, 11, 12, 13, 14). In studying the role of AO species in atherogenesis, we
observed that AO species stimulate c-Fos and c-Jun mRNA expression
and DNA synthesis in VSMC (15). We demonstrated that such AO
species-induced growth-related events require arachidonic acid release
and metabolism through the lipoxygenase pathway (16, 17, 18). In this
communication, we report identification of arachidonic acid metabolites
that may mediate oxidative stress-induced growth-related events in
VSMC. Specifically, hydrogen peroxide-stimulated production of 12- and
15-HETEs in VSMC and these eicosanoids were found to induce c-Fos and
c-Jun expression and AP-1 activity.
EXPERIMENTAL PROCEDURES
Materials
Arachidonic acid, 12- and
15-hydroperoxyeicosatetraenoic acids, and prostaglandin E2
were from Cayman Chemical Co., Inc. (Ann Arbor, MI). Anti-c-Fos and
anti-c-Jun rabbit polyclonal antibodies were purchased from Santa Cruz
Biotechnology Inc. (Santa Cruz, CA) and Oncogene Science Inc.
(Uniondale, NY), respectively. Nordihydroguaiaretic acid was purchased
from Aldrich. AP-1 and NF B consensus double-stranded
oligonucleotides and T4 polynucleotide kinase were from Promega
(Madison, WI). [5,6,8,9,11,12,14,15-3H]Arachidonic acid
(221 Ci/mmol), [ -32P]ATP (3000 Ci/mmol), and
[14C]chloramphenicol (59 mCi/mmol) were obtained from
Dupont NEN.
Cell Culture
VSMC were isolated from the thoracic aortas of
200-250-g male Sprague-Dawley rats by enzymatic digestion as described
earlier (15). Cells were grown in Dulbecco's modified Eagle's medium
(DMEM) supplemented with 10% (v/v) heat-inactivated calf serum, 100 units/ml penicillin, and 100 µg/ml streptomycin. Cultures were
maintained at 37 °C in a humidified 5% CO2
atmosphere.
Extraction of [3H]Arachidonic Acid
Metabolites
VSMC were plated onto 100-mm dishes and grown in DMEM
containing 10% calf serum and 15 µCi/ml
[3H]arachidonic acid (10 µM final
concentration) for 24 h. Cells were then growth-arrested by
incubation in DMEM containing 0.1% calf serum and 5 µCi/ml
[3H]arachidonic acid for 72 h. In all experiments,
cells were used that incorporated approximately the same amounts of the
label as assessed by counts/min/mg of protein. After the growth arrest
period, the medium was removed, and cells were washed twice with
phosphate-buffered saline (PBS) and stimulated with and without
hydrogen peroxide (200 µM) in DMEM containing 0.1% calf
serum. Radiolabeled arachidonic acid metabolites released into the
medium were extracted and analyzed as described previously (19).
Western Blot Analysis
VSMC were plated onto 60-mm dishes
and grown in DMEM containing 10% calf serum. At 70-80% confluence,
cells were growth-arrested by incubating for 72 h in DMEM
containing 0.1% calf serum. Growth-arrested VSMC were treated with and
without the agent of interest for the indicated time periods at
37 °C. After treatments, the medium was removed, and cells were
rinsed with cold PBS and frozen immediately in liquid nitrogen. 200 µl of lysis buffer (PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate,
0.1% SDS, 100 µg/ml phenylmethylsulfonyl fluoride, 100 µg/ml
aprotinin, and 1 mM sodium orthovanadate) was added to the
frozen monolayers, thawed on ice for 15 min, and scraped into 1.5-ml
Eppendorf tubes. The cell lysates were cleared by centrifugation at
12,000 × g for 20 min at 4 °C. The protein
concentration of the supernatants was determined using the Bradford
reagent (Bio-Rad). Cell lysates containing equal amounts of protein (30 µg/lane) were analyzed by Western blotting for c-Fos and c-Jun
proteins using specific antibodies as described earlier (20).
Nuclear Extract Preparation and Gel Mobility Shift
Assays
Growth-arrested VSMC were treated with and without the
agents of interest for the indicated times, and nuclear extracts were
prepared as described earlier (20). Protein-DNA complexes were formed
by incubating 5 µg of nuclear protein in a total volume of 20 µl
consisting of 15 mM Hepes, pH 7.9, 3 mM
Tris-HCl, pH 7.9, 60 mM KCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM
dithiothreitol, 4.5 µg of bovine serum albumin, 2 µg of
poly(dI-dC), 15% glycerol, and 100,000 cpm of 32P-labeled
oligonucleotide probe for 20 min at 30 °C. Protein-DNA complexes
were resolved on a 4% polyacrylamide gel using 0.25 × TBE buffer
(1 × TBE = 50 mM Tris borate, pH 8.3, and 1 mM EDTA). Double-stranded oligonucleotides (AP-1,
5 -CGCTTGATGAGTCAGCCGGAA-3 ; NF B, 5 -AGTTGAGGGGACTTTCCCAGGC-3 ) were
labeled with [ -32P]ATP using a T4 polynucleotide
kinase kit per the protocol of the supplier (Promega). Unincorporated
nucleotides were removed by chromatography in a G-25 spin column
(Bio-Rad).
Transient Transfection and CAT Assays
Existing VSMC culture
was split evenly into 100-mm dishes and grown in DMEM containing 10%
calf serum overnight. Cells were transfected with the plasmid DNA of
interest (25 µg/100-mm dish) using a calcium phosphate precipitation
method as described by Angel et al. (21). 16 h after
initiation of transfection, cells were washed with PBS and quiesced by
incubating in DMEM containing 0.1% calf serum for 36 h at
37 °C and then stimulated with an appropriate agent for 6 h.
Cells were again washed with PBS, scraped in 1 ml of TEN buffer (40 mM Tris-HCl, pH 7.5, 1 mM EDTA, pH 8.0, 150 mM NaCl) into an Eppendorf tube, and pelleted by
centrifugation at 12,000 × g for 1 min at 4 °C. The
cell pellet was suspended in 100 µl of cold 0.25 M
Tris-HCl buffer, pH 7.5, and the cells were lysed by three repeated
freeze-thaw cycles. Cell debris was removed by centrifugation at
12,000 × g for 5 min at 4 °C. Protein concentration
of the supernatant was determined as described above. CAT activity was
measured by the method of Gorman et al. (22). In brief, 50 µg of protein from each condition was incubated with 20 µl of 4 mM acetyl-CoA, 32.5 µl of 1 M Tris-HCl
buffer, pH 7.5, 4 µl of 50 µCi/ml
[14C]chloramphenicol in a total volume of 150 µl at
37 °C for 2-4 h. Controls without cell extract and/or with
non-transfected cell extracts were incubated simultaneously. Acetylated
and non-acetylated chloramphenicol was extracted with ethyl acetate and
separated by thin layer chromatography on Silica Gel 1B plates using a
chloroform:methanol mixture (19:1) as solvent. Following
autoradiography, percent acetylation was calculated by cutting out the
corresponding acetylated and non-acetylated spots of the TLC plate and
counting the radioactivity as described above.
RESULTS AND DISCUSSION
To determine the arachidonic acid metabolites whose synthesis was
modulated in response to oxidative stress, VSMC were labeled with
[3H]arachidonic acid, growth-arrested, and treated with
and without hydrogen peroxide (200 µM) for 1 h. The
labeled arachidonic acid metabolites released into the medium were
extracted and analyzed by reverse phase HPLC. Constitutive but low
levels of 15-HPETE release were observed from
[3H]arachidonic acid-prelabeled VSMC (Fig.
1A). Hydrogen peroxide treatment increased
production of 12- and 15-HPETE and prostaglandin (PG) E2
2.5-fold as compared with untreated cells (Fig. 1B). The
time course profile of eicosanoid generation by hydrogen peroxide did
not change for at least 2 h although the peaks were increased
proportionally to the length of treatment. In addition, about 15 and
12% of the released [3H]arachidonic acid was found to be
converted to 12- and 15-HPETE, respectively, in response to hydrogen
peroxide treatment. Earlier, we reported that hydrogen peroxide induces
c-Fos and c-Jun mRNA expression and DNA synthesis in VSMC and that
these events are sensitive to inhibition by nordihydroguaiaretic acid
(NDGA), a potent inhibitor of the lipoxygenase pathway (17, 18). To
determine whether hydrogen peroxide-stimulated production of 12- and
15-HPETE was also sensitive to inhibition by NDGA, VSMC prelabeled with
[3H]arachidonic acid and growth-arrested were treated
with hydrogen peroxide both in the presence and absence of NDGA (cells
were pretreated with 10 µM NDGA, for 30 min prior to
hydrogen peroxide addition), and the released arachidonic acid
metabolites were measured as described above. NDGA completely blocked
the hydrogen peroxide-induced production of 12- and 15-HPETE (Fig.
1C). NDGA enhanced hydrogen peroxide-induced
PGE2 synthesis. This finding is expected because inhibition
of the lipoxygenase pathway results in increased arachidonic acid
substrate availability for metabolism by cyclooxygenase. This result
also argues strongly against the antioxidant effect of NDGA because a
decrease both in HPETE and PGE2 production induced by
hydrogen peroxide would be otherwise expected. Collectively, these
observations suggest that hydrogen peroxide induces the synthesis of
eicosanoids in VSMC and that both the lipoxygenase and the
cyclooxygenase pathways are regulated in response to oxidative
stress.
Fig. 1.
Hydrogen peroxide induces synthesis of
eicosanoids in VSMC. [3H]Arachidonic acid-labeled
and growth-arrested VSMC were stimulated for 1 h with and without
200 µM hydrogen peroxide. The labeled arachidonic acid
metabolites released into the culture medium were extracted and
analyzed by reverse phase HPLC. Retention times were compared with
3H-labeled standards. A, labeled arachidonic
acid metabolites formed by VSMC; B, labeled arachidonic acid
metabolites formed by VSMC in response to hydrogen peroxide; and
C, labeled arachidonic acid metabolites formed by VSMC in
response to hydrogen peroxide in the presence of NDGA (10 µM), a lipoxygenase inhibitor. Retention times of
authentic 3H-labeled eicosanoid standards are indicated
with arrows in panel A as follows: 1,
PGE2; 2, PGF2 ; 3,
leukotriene C4; 4, leukotriene B4;
5, 12(S)-hydroxyheptadecatrienoic acid;
6, 15-HETE; 7, 12-HETE; 8, 5-HETE; and
9, arachidonic acid.
[View Larger Version of this Image (17K GIF file)]
Since hydrogen peroxide-induced growth-related events are sensitive to
inhibition by NDGA, we wanted to test whether 12- and 15-HPETE mediate
oxidative stress-induced c-Fos and c-Jun expression. To address this
issue, we studied the effect of 12- and 15-HPETE on c-Fos and c-Jun
expression in VSMC. Growth-arrested VSMC were treated for various time
periods with 12- and/or 15-HPETE (1 µM), and cell lysates
were prepared. 30 µg of protein from each time period were analyzed
by Western blotting for c-Fos and c-Jun proteins using their respective
antibodies. As shown in Fig. 2A, both 12- and
15-HPETE stimulated the expression of c-Fos and c-Jun proteins in a
time-dependent manner. A maximum 3-fold increase in c-Fos
and c-Jun protein expression in response to 12- and 15-HPETE was
observed at 2 h after initiation of treatment, and this response
persisted for at least 6 h. Note that 12-HPETE was found to be
more potent in inducing c-Fos and c-Jun expression than was 15-HPETE.
To determine whether hydrogen peroxide, which caused an increase in
eicosanoid production in VSMC, and arachidonic acid, the precursor of
eicosanoids, also stimulate c-Fos and c-Jun expression, growth-arrested
VSMC were treated with these agents for 2 h, and cell lysates were
prepared. Cell lysates containing equal amounts of protein (30 µg)
from each condition were then analyzed for c-Fos and c-Jun proteins by
Western blotting as described above. Both hydrogen peroxide (200 µM) and arachidonic acid (20 µM) treatments
caused significant increases in the expression of c-Fos and c-Jun as
compared with their controls, and these responses were inhibited by
NDGA (Fig. 2B).
Fig. 2.
12- and 15- HPETE, hydrogen peroxide, and
arachidonic acid stimulate c-Fos and c-Jun expression.
Growth-arrested VSMC were treated with and without the indicated
eicosanoids (1 µM) for the indicated times (A)
or with hydrogen peroxide (200 µM) or arachidonic acid
(20 µM) for 2 h (B), and cell extracts
were prepared. Equal amounts of proteins (30 µg) from treated and
untreated VSMC were then analyzed by Western blotting for c-Fos and
c-Jun using their respective antibodies. NDGA, wherever used, was added
30 min before the addition of the agent.
[View Larger Version of this Image (34K GIF file)]
As c-Fos and c-Jun are the major constituents of the transcriptional
factor AP-1 (23, 24) and HPETEs increased the expression of these
protooncogenes, we tested the effect of the same eicosanoids on AP-1
activation in VSMC. AP-1 activity was measured by its ability to bind
to the 12-O-tetradecanoylphorbol-13-acetate-responsive
element (TRE), TGACTCA. Nuclear extracts of 12-HPETE-treated VSMC
displayed 2-3-fold more TRE binding activity than extracts of
untreated VSMC, as determined by gel mobility shift assay (Fig.
3A). Almost maximal increases in AP-1-TRE
binding activity in response to 12-HPETE treatment were observed by
2 h, and these responses were persistent for at least 6 h.
Addition of NF B consensus cold oligonucleotide had no effect on
12-HPETE-induced AP-1-TRE binding (Fig. 3A, lane
5). On the other hand, the addition of excess cold TRE to the
reaction mix reduced AP-1 binding to 32P-labeled TRE (Fig.
3A, lanes 6 and 7). The latter two
observations clearly indicate that the AP-1-TRE binding activity
observed in the nuclear extracts of 12-HPETE-treated VSMC is specific.
A time course of 15-HPETE-stimulated AP-1-TRE binding activity yielded
results similar to those obtained with 12-HPETE (Fig. 3A).
Addition of excess cold TRE (100-fold) to the reaction mix also
competed with the labeled probe for binding to AP-1 in the nuclear
extracts of 15-HPETE-treated VSMC (data not shown). As noticed in Fig.
3, differential basal AP-1-DNA binding activities were observed between
different experiments. This may be due to different levels of VSMC
growth arrest in different experiments. Nuclear extracts of VSMC that
were treated with hydrogen peroxide and/or arachidonic acid for 2 or
4 h had significantly higher AP-1-TRE binding activities in
comparison with extracts of untreated cells (Fig. 3B). NDGA,
which alone had no effect, significantly inhibited (75%) hydrogen
peroxide and arachidonic acid-induced AP-1 activity (Fig.
3B). Cell extracts of VSMC that were transiently transfected
with 73/+63 collagenase-CAT and exposed to hydrogen peroxide (100 µM), arachidonic acid (20 µM), 12-HPETE (1 µM), or 15-HPETE (1 µM) for 6 h also
showed a 2-fold increase in CAT activity as compared with extracts of
untreated cells (Fig. 4). The -fold increases in CAT
activities in treated versus control cells are comparatively
less than the apparent increases in AP-1-TRE binding assays. This may
be explained by differences between episomal and chromosomal gene
regulation.
Fig. 3.
12- and 15- HPETE, hydrogen peroxide, and
arachidonic acid stimulate AP-1-DNA binding activity in VSMC.
A, nuclear extracts (5 µg) of 0 (control), 2, 4, and
6 h of 12-HPETE-treated VSMC (lanes 1-4, respectively)
were incubated with radiolabeled AP-1-specific oligonucleotide, and the
AP-1-DNA complex was separated from the free probe on a 4%
non-denaturing polyacrylamide gel. Cold NF B (100-fold, lane
5) and AP-1 (10-fold, lane 6; and 100-fold, lane
7), respectively, were added to the nuclear extract of
12-HPETE-treated (6 h) VSMC prior to incubation with radiolabeled AP-1
oligonucleotide probes. Lanes 8-12 are nuclear extracts of
0 (control), 1, 2, 4, and 6 h of 15-HPETE-treated VSMC,
respectively, that were incubated with a radiolabeled AP-1
oligonucleotide probe. B, treatments of VSMC are as follows:
lane 1, control; lane 2, hydrogen peroxide for
2 h; lane 3, hydrogen peroxide for 4 h; lane
4, arachidonic acid for 2 h; lane 5, arachidonic
acid for 4 h; lane 6, hydrogen peroxide for 2 h
but in the presence of NDGA; lane 7, arachidonic acid for
2 h but in the presence of NDGA; and lane 8, NDGA
alone. 5 µg of nuclear proteins from each treatment were incubated
with radiolabeled AP-1 oligonucleotide probe, and the products were
separated on PAGE as described above. NDGA, wherever used, was added 30 min before the addition of the agent.
[View Larger Version of this Image (66K GIF file)]
Fig. 4.
Hydrogen peroxide, arachidonic acid,
12-HPETE, and 15-HPETE induce AP-1-dependent reporter gene
transcription in VSMC. VSMC were transiently transfected with
73/+63 collagenase-CAT reporter plasmid, growth-arrested, and treated
with and without hydrogen peroxide (100 µM), arachidonic
acid (20 µM), 12-HPETE (1 µM), or 15-HPETE
(1 µM) for 6 h, and cell extracts were prepared. CAT
activities in the cell lysates were assayed as described under
``Experimental Procedures.'' The -fold increases in CAT activities
over control are: hydrogen peroxide, 2.0; arachidonic acid, 4.2;
15-HPETE, 2.4; and 12-HPETE, 2.4.
[View Larger Version of this Image (49K GIF file)]
The novel finding of the present study is that hydrogen peroxide
induces the synthesis of 12- and 15-HPETE in VSMC and that these
eicosanoids possess the ability to activate AP-1. Work from several
laboratories suggests that lipoxygenase inhibitors exhibit
antiproliferative activity (25, 26). In addition, the ability of
arachidonic acid and its lipoxygenase metabolites such as 12- and
15-HPETE to act as mitogens of several cell types has been demonstrated
(27, 28). Some studies have reported that growth factors such as
epidermal growth factor and serum require arachidonic acid release and
metabolism through the lipoxygenase pathway for induction of growth in
certain cell types (29, 30). Natarajan et al. (31) have
demonstrated that angiotensin II requires 12-HPETE production for its
hypertrophic effect in rabbit aortic smooth muscle cells. We have
previously shown that oxidative stress induces c-Fos and c-Jun mRNA
expression and DNA synthesis in VSMC and that these events require
arachidonic acid release and metabolism via the lipoxygenase pathway
(15, 16, 17). Because the lipoxygenase metabolites of arachidonic acid have
been shown to be critical in the modulation of growth in response to
certain peptide growth factors and hydrogen peroxide increased the
production of lipoxygenase metabolites of arachidonic acid such as 12- and 15-HPETE, it is likely that these eicosanoids, at least in part,
mediate the oxidative stress-induced growth-related events in VSMC.
This idea can be further supported by our finding that 12- and 15-HPETE
are capable of stimulating c-Fos and c-Jun expression and AP-1 activity
in VSMC. However, a role for other enzymatic or non-enzymatic products
of arachidonic acid or linoleic acid in oxidant-mediated cell responses
cannot be ruled out. In fact, since hydrogen peroxide treatment, in
addition to 12- and 15-HPETE, increased the production of at least one
more [3H]arachidonic acid-derived product that elutes
between 76 and 78 min in this reverse phase HPLC system and the
synthesis of this compound was somewhat sensitive to inhibition by
NDGA, it is possible that this molecule may also be involved in
oxidant-mediated cell responses. Future studies should identify this
compound and examine whether it modulates growth response events in
these cells. In addition, we recently found that 4-hydroxynonenal, an
aldehyde that can be produced non-enzymatically from arachidonic acid,
linoleic acid, or their hydroperoxides (32), stimulates c-Fos and c-Jun
expression and DNA synthesis in VSMC.2
Thus, polyunsaturated fatty acids, their hydroperoxides, and probably
the non-enzymatic breakdown products of these lipid molecules may alone
or in combination play an important role in the pathogenesis of lesions
such as atherosclerosis and cancer that are linked to oxidative stress.
Indeed, increased levels of HPETEs were reportedly observed in
atherosclerotic arteries (33, 34) and in certain forms of cancer (35),
and the enzymes responsible for their production are present in many
cell types including arterial smooth muscle cells (31, 36, 37). Since
hydrogen peroxide was capable of up-regulating the levels of HPETEs and
these HPETEs are growth modulators to some cells, one possible
mechanism by which oxidative stress could influence atherogenesis is by
stimulation of smooth muscle cell growth via generation of eicosanoids
such as the ones we observed.
Smooth muscle cell migration to and their multiplication in intima
appeared to be one of several determinant factors in atherogenesis
(38). HPETEs were reported to be potent chemoattractants for various
cell types including VSMC (39). Since hydrogen peroxide increased the
production of 12- and 15-HPETE, it is also tempting to speculate that
oxidative stress modulates VSMC migration in an autocrine manner. This
event can even be further compounded by the fact that VSMC production
of HPETEs induced by oxidative stress may influence migration of
neutrophils, macrophages, and platelets to and their deposition in the
intima. If this is, indeed, true then antioxidant therapies as
suggested by Steinberg (40) could modify the atherosclerosis
process.
FOOTNOTES
*
This work was supported in part by a grant from the American
Heart Association, Texas Affiliate (to G. N. R.). The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
``advertisement'' in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: University of Texas
Medical Branch, 9.138 Medical Research Bldg., Rt. 1064, 301 University Blvd., Galveston, TX 77555-1064. Tel.: 409-747-1851;
Fax: 409-747-0692.
1
The abbreviations used are: AO, active oxygen;
AP-1, activating protein 1; HPETE, hydroperoxyeicosatetraenoic acid;
HPLC, high performance liquid chromatography; NDGA,
nordihydroguaiaretic acid; PG, prostaglandin; VSMC, vascular smooth
muscle cells; DMEM, Dulbecco's modified Eagle's medium; PBS,
phosphate-buffered saline; CAT, chloramphenicol acetyltransferase; TRE,
12-O-tetradecanoylphorbol-13-acetate-responsive element;
HETE, hydroxyeicosatetraenoic acid.
2
G. N. Rao, J. Ruef, and M. S. Runge, unpublished
observations.
Acknowledgments
We thank Dr. Mikael Karin of the University
of California, San Diego, for providing us with 73/+63
collagenase-CAT plasmid. We also thank Barbara L. Murphy for
secretarial support and Joann Aaron for editorial assistance.
REFERENCES
-
Fridovich, I.
(1978)
Science
201,
875-880
[Abstract/Free Full Text]
-
Cerutti, P. A.
(1985)
Science
227,
375-381
[Abstract/Free Full Text]
-
Jolly, S. R.,
Kane, W. F.,
Bailie, M. B.,
Abrams, G. D.,
Lucchesi, B. R.
(1984)
Circ. Res.
54,
277-285
[Abstract/Free Full Text]
-
Fantone, J. L.,
Ward, P. A.
(1982)
Am. J. Pathol.
107,
394-418
-
Floyd, R. A.
(1990)
FASEB J.
4,
2587-2597
[Abstract]
-
Halliwell, B.
(1989)
Br. J. Exp. Pathol.
70,
737-757
[Medline]
[Order article via Infotrieve]
-
Cerutti, P. A.,
Trump, B. F.
(1991)
Cancer Cells
3,
1-7
[Medline]
[Order article via Infotrieve]
-
Crawford, D. W.,
Blankenhorn, D. H.
(1991)
Atherosclerosis
89,
97-108
[CrossRef][Medline]
[Order article via Infotrieve]
-
Witztum, J. L.,
Steinberg, D.
(1991)
J. Clin. Invest.
88,
1785-1792
-
Crawford, D.,
Zbinden, I.,
Amstad, P.,
Cerutti, P. A.
(1988)
Oncogene
3,
27-32
-
Shibanuma, M.,
Kuroki, T.,
Nose, K.
(1990)
Oncogene
5,
1025-1032
[Medline]
[Order article via Infotrieve]
-
Maki, A.,
Berezesky, I. K.,
Fargnoli, J.,
Holbrook, N. J.,
Trump, B. F.
(1992)
FASEB J.
6,
919-924
[Abstract]
-
Crane, F. L.,
Sun, I. L.,
Clark, M. G.,
Grebing, C.,
Low, H.
(1985)
Biochim. Biophys. Acta
811,
233-264
[Medline]
[Order article via Infotrieve]
-
Murrell, G. A.,
Francis, M. J.,
Bromley, L.
(1990)
Biochem. J.
265,
659-665
[Medline]
[Order article via Infotrieve]
-
Rao, G. N.,
Berk, B. C.
(1992)
Circ. Res.
70,
593-599
[Abstract/Free Full Text]
-
Rao, G. N.,
Lassegue, B.,
Griendling, K. K.,
Alexander, R. W.,
Berk, B. C.
(1993)
Nucleic Acids Res.
21,
1259-1263
[Abstract/Free Full Text]
-
Rao, G. N.,
Lassegue, B.,
Griendling, K. K.,
Alexander, R. W.
(1993)
Oncogene
8,
2759-2764
[Medline]
[Order article via Infotrieve]
-
Rao, G. N.,
Runge, M. S.,
Alexander, R. W.
(1995)
Biochim. Biophys. Acta
1265,
67-72
[Medline]
[Order article via Infotrieve]
-
Rao, G. N.,
Baas, A. S.,
Glasgow, W. C.,
Eling, T. E.,
Runge, M. S.,
Alexander, R. W.
(1994)
J. Biol. Chem.
269,
32586-32591
[Abstract/Free Full Text]
-
Rao, G. N.,
Runge, M. S.
(1996)
J. Biol. Chem.
271,
20805-20810
[Abstract/Free Full Text]
-
Angel, P.,
Imagawa, M.,
Chiu, R.,
Stein, B.,
Imbra, R. J.,
Rahmsdorf, H. J.,
Jonat, C.,
Herrlich, P.,
Karin, M.
(1987)
Cell
49,
729-739
[CrossRef][Medline]
[Order article via Infotrieve]
-
Gorman, C. M.,
Moffat, L. F.,
Howard, B. H.
(1982)
Mol. Cell. Biol.
2,
1044-1051
[Abstract/Free Full Text]
-
Angel, P.,
Karin, M.
(1991)
Biochim. Biophys. Acta
1072,
129-157
[Medline]
[Order article via Infotrieve]
-
Curran, T.,
Faranza, B. R. J.
(1988)
Cell
55,
395-397
[CrossRef][Medline]
[Order article via Infotrieve]
-
Miller, A. M.,
Cullen, M. K.,
Kobb, S. M.,
Weiner, R. S.
(1989)
J. Lab. Clin. Med.
113,
355-361
[Medline]
[Order article via Infotrieve]
-
Ralph, R. K.,
Wojcik, S.
(1990)
Cancer Lett.
49,
181-185
[CrossRef][Medline]
[Order article via Infotrieve]
-
Setty, B. N. Y.,
Graeber, J. E.,
Stuart, M. J.
(1987)
J. Biol. Chem.
262,
17613-17622
[Abstract/Free Full Text]
-
Postoak, D.,
Nystuen, L.,
King, L.,
Ueno, M.,
Beckman, B. S.
(1990)
Am. J. Physiol.
259,
C849-C853
[Abstract/Free Full Text]
-
Handler, J. A.,
Danilowicz, R. M.,
Eling, T. E.
(1990)
J. Biol. Chem.
265,
3669-3673
[Abstract/Free Full Text]
-
Sellmayer, A.,
Uedelhoven, W. M.,
Wever, P. C.,
Bonventre, J. V.
(1991)
J. Biol. Chem.
266,
3800-3807
[Abstract/Free Full Text]
-
Natarajan, R.,
Gu, J. L.,
Rossi, J.,
Gonzales, N.,
Lanting, L.,
Xu, L.,
Nadler, J.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
4947-4951
[Abstract/Free Full Text]
-
Esterbauer, H.,
Benedetti, A.,
Lang, J.,
Fulceri, R.,
Fauler, G.,
Comporti, M.
(1986)
Biochim. Biophys. Acta
876,
154-166
[Medline]
[Order article via Infotrieve]
-
Henriksson, P.,
Hamberg, M.,
Diczfalusy, U.
(1985)
Biochim. Biophys. Acta
834,
272-274
[Medline]
[Order article via Infotrieve]
-
Wang, T.,
Powell, W. S.
(1991)
Biochim. Biophys. Acta
1084,
129-138
[Medline]
[Order article via Infotrieve]
-
Hammarstrom, S.,
Hamberg, M.,
Samuelsson, B.,
Duell, E. A.,
Stawiski, M.,
Voorhees, J. J.
(1975)
Proc. Natl. Acad. Sci. U. S. A.
72,
5130-5134
[Abstract/Free Full Text]
-
Hada, T.,
Hagiyz, H.,
Suzuki, H.,
Arakawa, T.,
Nakamura, M.,
Matsuda, S.,
Yoshimoto, T. S.,
Yamamoto, S.,
Azekawa, T.,
Morita, Y.,
Ishimura, K.,
Kim, H. Y.
(1994)
Biochim. Biophys. Acta
1211,
221-228
[Medline]
[Order article via Infotrieve]
-
Yla-Herttuala, S.,
Rosenfeld, M. E.,
Parthasarathy, S.,
Sigal, E.,
Sarkioja, T.,
Witztum, J. L.,
Steinberg, D.
(1991)
J. Clin. Invest.
87,
1146-1152
-
Ross, R.
(1993)
Nature
362,
801-809
[CrossRef][Medline]
[Order article via Infotrieve]
-
Nakao, J.,
Ooyama, T.,
Ito, H.,
Chang, W. C.,
Muorta, S.
(1982)
Atherosclerosis
44,
339-342
[CrossRef][Medline]
[Order article via Infotrieve]
-
Steinberg, D.
(1992)
Circulation
85,
2338-2344
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. GOUNI-BERTHOLD and A. SACHINIDIS
Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells?
FASEB J,
October 1, 2002;
16(12):
1477 - 1487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Shen and A. Sevanian
OxLDL induces macrophage {{gamma}}-GCS-HS protein expression: a role for oxLDL-associated lipid hydroperoxide in GSH synthesis
J. Lipid Res.,
May 1, 2001;
42(5):
813 - 823.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Watanabe, R. Pakala, S. Koba, T. Katagiri, and C. R. Benedict
Lysophosphatidylcholine and Reactive Oxygen Species Mediate the Synergistic Effect of Mildly Oxidized LDL With Serotonin on Vascular Smooth Muscle Cell Proliferation
Circulation,
March 13, 2001;
103(10):
1440 - 1445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. He and M. C. LaPointe
Src and Rac Mediate Endothelin-1 and Lysophosphatidic Acid Stimulation of the Human Brain Natriuretic Peptide Promoter
Hypertension,
February 1, 2001;
37(2):
478 - 484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kuwata, S. Yamamoto, Y. Miyazaki, S. Shimbara, Y. Nakatani, H. Suzuki, N. Ueda, S. Yamamoto, M. Murakami, and I. Kudo
Studies on a Mechanism by Which Cytosolic Phospholipase A2 Regulates the Expression and Function of Type IIA Secretory Phospholipase A2
J. Immunol.,
October 1, 2000;
165(7):
4024 - 4031.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wolfle, S. Marotzki, D. Dartsch, W. Schafer, and H. Marquardt
Induction of cyclooxygenase expression and enhancement of malignant cell transformation by 2,3,7,8-tetrachlorodibenzo- p-dioxin
Carcinogenesis,
January 1, 2000;
21(1):
15 - 21.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Koba, R. Pakala, T. Watanabe, T. Katagiri, and C. R. Benedict
Vascular smooth muscle proliferation: Synergistic interaction between serotonin and low density lipoproteins
J. Am. Coll. Cardiol.,
November 1, 1999;
34(5):
1644 - 1651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wartenberg, H. Diedershagen, J. Hescheler, and H. Sauer
Growth Stimulation Versus Induction of Cell Quiescence by Hydrogen Peroxide in Prostate Tumor Spheroids Is Encoded by the Duration of the Ca2+ Response
J. Biol. Chem.,
September 24, 1999;
274(39):
27759 - 27767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Arai, H. Imai, T. Koumura, M. Yoshida, K. Emoto, M. Umeda, N. Chiba, and Y. Nakagawa
Mitochondrial Phospholipid Hydroperoxide Glutathione Peroxidase Plays a Major Role in Preventing Oxidative Injury to Cells
J. Biol. Chem.,
February 19, 1999;
274(8):
4924 - 4933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Uchida, M. Shiraishi, Y. Naito, Y. Torii, Y. Nakamura, and T. Osawa
Activation of Stress Signaling Pathways by the End Product of Lipid Peroxidation. 4-HYDROXY-2-NONENAL IS A POTENTIAL INDUCER OF INTRACELLULAR PEROXIDE PRODUCTION
J. Biol. Chem.,
January 22, 1999;
274(4):
2234 - 2242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Natarajan, S. Scott, W. Bai, K. K. V. Yerneni, and J. Nadler
Angiotensin II Signaling in Vascular Smooth Muscle Cells Under High Glucose Conditions
Hypertension,
January 1, 1999;
33(1):
378 - 384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Lakshminarayanan, E. A. Drab-Weiss, and K. A. Roebuck
H2O2 and Tumor Necrosis Factor-alpha Induce Differential Binding of the Redox-responsive Transcription Factors AP-1 and NF-kappa B to the Interleukin-8 Promoter in Endothelial and Epithelial Cells
J. Biol. Chem.,
December 4, 1998;
273(49):
32670 - 32678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hocker, I. Rosenberg, R. Xavier, R. J. Henihan, B. Wiedenmann, S. Rosewicz, D. K. Podolsky, and T. C. Wang
Oxidative Stress Activates the Human Histidine Decarboxylase Promoter in AGS Gastric Cancer Cells
J. Biol. Chem.,
September 4, 1998;
273(36):
23046 - 23054.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ruef, G. N. Rao, F. Li, C. Bode, C. Patterson, A. Bhatnagar, and M. S. Runge
Induction of Rat Aortic Smooth Muscle Cell Growth by the Lipid Peroxidation Product 4-Hydroxy-2-Nonenal
Circulation,
March 24, 1998;
97(11):
1071 - 1078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Kenney and J. D. Kocsis
Peripheral Axotomy Induces Long-Term c-Jun Amino-Terminal Kinase-1 Activation and Activator Protein-1 Binding Activity by c-Jun and junD in Adult Rat Dorsal Root Ganglia In Vivo
J. Neurosci.,
February 15, 1998;
18(4):
1318 - 1328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ramasamy, S. Parthasarathy, and D. G. Harrison
Regulation of endothelial nitric oxide synthase gene expression by oxidized linoleic acid
J. Lipid Res.,
February 1, 1998;
39(2):
268 - 276.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Imai, K. Narashima, M. Arai, H. Sakamoto, N. Chiba, and Y. Nakagawa
Suppression of Leukotriene Formation in RBL-2H3 Cells That Overexpressed Phospholipid Hydroperoxide Glutathione Peroxidase
J. Biol. Chem.,
January 23, 1998;
273(4):
1990 - 1997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kuwata, Y. Nakatani, M. Murakami, and I. Kudo
Cytosolic Phospholipase A2 Is Required for Cytokine-induced Expression of Type IIA Secretory Phospholipase A2 That Mediates Optimal Cyclooxygenase-2-dependent Delayed Prostaglandin E2 Generation in Rat 3Y1 Fibroblasts
J. Biol. Chem.,
January 16, 1998;
273(3):
1733 - 1740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. LaPointe and J. R. Sitkins
Phospholipase A2 Metabolites Regulate Inducible Nitric Oxide Synthase in Myocytes
Hypertension,
January 1, 1998;
31(1):
218 - 224.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|